• Home
  • /
  • Shop
  • /
  • International Journal of Antibiotics

International Journal of Antibiotics

1,975  7,315 Price range: 1,975 ₹ through 7,315 ₹

The International Journal of Antibiotics (IJA) is a peer-reviewed scientific journal that publishes high-quality original research, reviews, and case studies related to antibiotic development, mechanisms of action, resistance, and clinical applications. IJA serves as a vital resource for microbiologists, pharmacologists, clinicians, researchers, and healthcare policymakers engaged in the global effort to combat infectious diseases and antimicrobial resistance (AMR).

Add to Wishlist
Add to Wishlist
SKU: ijab Category: Tag: Brand:

International Journal of Antibiotics

The International Journal of Antibiotics by STM Journals is a leading peer-reviewed publication focused on advanced research in antibiotic development, mechanisms of action, and antimicrobial resistance. It serves as a trusted resource for researchers, educators, nursing professionals, public-health experts, and students seeking reliable updates on modern antibiotic therapies and resistance management.

What This Journal Covers: Key Focus Areas

Our journal explores a wide array of critical topics in the field of antibiotic discovery, resistance, and treatment. Key focus areas include:

  • Discovery and Development of New Antibiotics: Investigating novel antibiotics to combat emerging bacterial pathogens and address global health challenges.

  • Mechanisms of Antibiotic Resistance and Resistance Genes: Understanding how bacteria evolve resistance mechanisms and the genetic factors involved in resistance spread.

  • Antibiotic Pharmacology and Pharmacokinetics: Research on the absorption, distribution, metabolism, and excretion of antibiotics, optimizing their therapeutic use.

  • Clinical Trials and Therapeutic Applications of Antibiotics: Examining the clinical efficacy of antibiotics and exploring new therapeutic applications to fight infectious diseases.

  • Antimicrobial Stewardship and Resistance Mitigation Strategies: Developing strategies for appropriate antibiotic use, reducing resistance through stewardship, and promoting global health policies.

Each of these areas drives forward the science of antibiotic development and resistance mitigation, shaping the future of infectious disease treatment and public health.

Who Should Read This Journal

  • Microbiologists and pharmacologists researching antibiotics

  • Healthcare professionals managing infectious diseases

  • Public health experts focusing on antibiotic resistance

  • Educators and students in medicine, pharmacy, and biological sciences

  • Policy makers developing antimicrobial regulations and guidelines

Why This Journal Matters

Antibiotic resistance is one of the most pressing challenges in modern medicine. This journal:

  • Provides a trusted platform for peer-reviewed research addressing resistance

  • Supports innovation in antibiotic discovery and clinical application

  • Bridges laboratory findings with public health and clinical practices

  • Enhances understanding of stewardship and global health impact

Why Choose STM Journals?

STM Journals offers:

  • Thorough double-blind peer review ensuring scientific rigor

  • Broad international readership connecting researchers and clinicians

  • Convenient access through online platforms and print editions

  • Editorial expertise committed to advancing antibiotic research

Subscription and Access Options

The International Journal of Antibiotics is accessible via:

  • Online Access: Immediate digital access to current and archived issues via STM Journals’ platform.

  • Print Subscription: Physical copies available for institutions and individual readers preferring print.

Custom institutional and bulk subscription plans are offered to support academic and healthcare institutions.

About Journal

International Journal of Antibiotics [2584-2986(e)] is a peer-reviewed open-access journal launched in 2024 that publishes original research articles, reviews, and perspectives in the field of antibiotics and antimicrobial agents. The journal aims to provide a platform for researchers, …

The journal welcomes original research articles, reviews, and perspectives on any aspect of antibiotics and antimicrobial agents, including but not limited to, basic research, clinical trials, epidemiological studies, and policy and practice. The journal also encourages submissions from a broad range of disciplines, including microbiology, pharmacology, immunology, infectious diseases, and public health.

The journal aims to disseminate new knowledge and insights that can contribute to improving the use and effectiveness of antibiotics, as well as to reduce the development and spread of antibiotic resistance.


View Editorial Board

Journal Information

Title: International Journal of Antibiotics Abbreviation: IJAB
Issues Per Year: 2 Issues E-ISSN: 2584-2986
Publisher: STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
DOI: 10.37591/IJAB Starting Year: 2024
Language: English Publication Format: Hybrid Open Access
Subject: Antibiotics Type: Peer-reviewed Journal (Refereed Journal)
Copyright Policy: CC BY-NC-ND

Indexing & Metrics

Indexing: Google Scholar, Scientific Literature (SCILIT)

ICV Value: 2024: 41.42

Impact Factor (SJIF): 2024: 3.519

Focus & Scope

Focus & Scope

An integrated antimicrobial framework—bridging the gap between chemical synthesis and drug design with clinical stewardship, resistance surveillance, and alternative therapeutic technologies.

Antibiotic R&D

High-throughput screening and structural biology for target identification. Research focuses on lead optimization of natural products, chemical synthesis, and lead compounds to improve drug metabolism and efficacy.

Molecular Resistance

Investigating beta-lactamases, efflux pumps, and modifying enzymes. Study of horizontal gene transfer (HGT) and the fitness cost of resistance genes in multidrug-resistant (MDR) bacterial populations.

Pharmacology & Dosing

Modeling ADME (Absorption, Distribution, Metabolism, Excretion) and clearance. Utilizing MIC (Minimum Inhibitory Concentration) and time-kill assays to optimize therapeutic drug monitoring and tissue penetration.

Stewardship & Surveillance

Promoting rational use via de-escalation and empiric therapy guidelines. Molecular epidemiology and surveillance systems track outbreaks in nosocomial and community settings to prevent AMR spread.

One Health & Veterinary Use

Managing antibiotic residues and growth promoters in livestock and aquaculture. Focus on zoonotic infections and the public health impact of agricultural antimicrobial use on the global food supply.

Emerging Therapies

Innovation in phage therapy, CRISPR-Cas9, and antimicrobial peptides. Exploring genome mining, metagenomics, and nanotechnology for drug delivery and non-traditional antibiotic adjuvants.

Contact Us

Contact Us
EX: Subscription, Publication, Complain, Support etc...

>
Select for currency